Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $19.9800 (8%) ($18.2000 - $20.0000) on Thu. Apr. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.76% (three month average) | RSI | 54 | Latest Price | $19.9800(8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 4.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(62%) ARKG(58%) IWO(57%) XBI(56%) ARKK(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.88% in a week (0% probabilities). VIXM(-30%) VXX(-14%) UUP(-14%) TBT(-4%) UNG(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.88% (StdDev 5.76%) | Hourly BBV | 0 () | Intraday Trend | 8% | | | |
|
5 Day Moving Average | $19.7(1.42%) | 10 Day Moving Average | $20.06(-0.4%) | 20 Day Moving Average | $19.74(1.22%) | To recent high | -39% | To recent low | 34.3% | Market Cap | $1.241b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |